港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

泰德醫藥

22.260

+0.4001.83%

成交量：10.03萬

成交額：220.99萬

市值：31.56億

市盈率：52.02

高：22.480

開：22.000

低：21.680

收：21.860

52周最高：41.720

52周最低：21.500

股本：1.42億

香港流通股本：1.42億

量比：0.98

換手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):0.428

淨資產收益率：12.46%

總資產收益率：6.53%

市淨率：1.89

市盈率(LYR):52.02

市銷率: 5.57

資料載入中...

總覽公司新聞資訊公告

泰德醫藥(03880.HK)擬3月30日召開董事會會議審批年度業績

泰德醫藥盤中異動早盤急速下跌6.79%

泰德醫藥（03880）更新翌日披露報表，已發行股本變動

泰德醫藥(03880)完成H股全流通

智通财经网

泰德醫藥（03880）2026年2月股份變動月報表，股本保持穩定

泰德醫藥盤中異動股價大跌5.10%報22.340港元

泰德醫藥盤中異動臨近午盤快速跳水5.07%報24.320港元

半年內股價腰斬，泰德醫藥(03880)年度盈喜利好也難獲市場青睞？

泰德醫藥盤中異動早盤股價大跌5.16%報25.380港元

泰德醫藥盤中異動早盤大幅上漲5.78%

泰德醫藥(03880)發盈喜，預期年度經調整淨利潤約2億元至2.3億元按年增加約16.3%至33.7%

泰德醫藥（浙江）股份有限公司2025年度營收約5.55億元至5.85億元，經調整淨利潤約2.00億元至2.30億元

泰德醫藥盤中異動快速下挫5.55%

泰德醫藥盤中異動股價大漲5.11%

泰德醫藥(03880)：中國證監會就公司H股全流通申請發出備案通知書

港股破發股泰德醫藥跌5.57%創新低上市募5.14億港元

泰德醫藥（03880）披露1月月報，股本結構維持穩定

泰德醫藥盤中異動下午盤股價大跌5.25%

泰德醫藥創歷史新低

泰德醫藥01月30日主力淨流入31.1萬元散户資金拋售

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/03880/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"泰德醫藥","latestPrice":22.26,"timestamp":1774338577432,"preClose":21.86,"halted":0,"volume":100300,"delay":0,"changeRate":0.01829826166514191,"floatShares":141800000,"shares":141800000,"eps":0.42794592118488833,"marketStatus":"已收盤","change":0.4,"latestTime":"03-24 15:49:37","open":22,"high":22.48,"low":21.68,"amount":2209916,"amplitude":0.036597,"askPrice":22.48,"askSize":500,"bidPrice":22.1,"bidSize":2100,"shortable":0,"etf":0,"ttmEps":0.9710195550406289,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":21.86,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.979875,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"6.53%","roe":"12.46%","lyrEps":0.427946,"volumeRatio":0.979875,"shares":141800000,"dividePrice":0,"high":22.48,"amplitude":0.036597,"preClose":21.86,"low":21.68,"week52Low":21.5,"pbRate":"1.89","psRate":"5.57","week52High":41.72,"institutionHeld":0,"latestPrice":22.26,"committee":0.615385,"eps":0.42794592118488833,"divideRate":0,"volume":100300,"delay":0,"ttmEps":0.9710195550406289,"open":22,"prevYearClose":30.48,"prevWeekClose":21.8,"prevMonthClose":25.62,"prevQuarterClose":30.48,"fiveDayClose":23,"twentyDayClose":26.46,"sixtyDayClose":30},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-03-23","current":22.924358,"percent":0.005525,"low":24.620311,"twenty":31.29937,"median":35.930996,"eighty":72.695936,"high":89.502411,"avg":44.174145,"sd":19.252513,"marketCap":3099748000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-23","current":24.642571,"twenty":31.29937,"median":35.930996,"eighty":72.695936,"marketCap":3099748000}],"updateTime":1774345950197},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619462645","title":"泰德醫藥(03880.HK)擬3月30日召開董事會會議審批年度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462645","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462645?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 23:07","pubTimestamp":1773673621,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨泰德医药(03880.HK)宣布，董事会会议将于2026年3月30日(星期一)召开，藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度的年度业绩及其刊发，并考虑派发末期股息之建议(如有)以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260316/32072725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2618516918","title":"泰德醫藥盤中異動 早盤急速下跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618516918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618516918?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 09:36","pubTimestamp":1773192986,"startTime":"0","endTime":"0","summary":"2026年03月11日早盘09时36分，泰德医药股票出现波动，股价大幅下跌6.79%。截至发稿，该股报21.700港元/股，成交量6400股，换手率0.00%，振幅6.01%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。泰德医药股票所在的药品行业中，整体涨幅为0.17%。泰德医药公司简介：泰德医药(浙江)股份有限公司是一家主要从事肽的合约研究、开发和制造的中国公司。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031109362697acd147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031109362697acd147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1108496966","title":"泰德醫藥（03880）更新翌日披露報表，已發行股本變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1108496966","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108496966?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:11","pubTimestamp":1773058303,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司（03880）于2026年3月9日发布翌日披露报表，公告将68,201,112股非上市股份转换为同等数量的H股。该等转换股份占变动前已发行股份总数的48.1%。\n本次转换完成后，公司H股数量从原先的73,598,888股增至141,800,000股，非上市股份相应降至0股。公司在公告中确认，已遵守相关上市规则及法律法规，并已取得董事会正式授权。\n据悉，公告由联席公司秘书吴东澄签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2618625621","title":"泰德醫藥(03880)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2618625621","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618625621?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:07","pubTimestamp":1773058021,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药(03880)发布公告，6820.11万股非上市股份转换为H股已于2026年3月9日完成，而转换H股将于2026年3月10日上午九时正起开始于联交所上市。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1183334294","title":"泰德醫藥（03880）2026年2月股份變動月報表，股本保持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1183334294","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183334294?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 16:59","pubTimestamp":1772614797,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司（03880）于2026年3月4日发布2026年2月股份变动月报表。报告期为2026年2月1日至2026年2月28日，公司股本结构资料如下：\n公司已发行股本中，H股数量为73,598,888股，非上市股份数量为68,201,112股，两部分合计已发行股本为141,800,000股。报告期内，公司未进行任何新增发行、回购或注销股份，也无库藏股变动。\n截至2026年2月28日，公司已发行股本总数维持不变。公司在公告中确认，相关股份事项均严格遵守香港联合交易所有限公司证券上市规则及相关法律法规。该月报表由公司联席公司秘书吴东澄签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2616538120","title":"泰德醫藥盤中異動 股價大跌5.10%報22.340港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616538120?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 11:07","pubTimestamp":1772593626,"startTime":"0","endTime":"0","summary":"2026年03月04日早盘11时07分，泰德医药股票出现异动，股价急速下跌5.10%。截至发稿，该股报22.340港元/股，成交量7.45万股，换手率0.10%，振幅7.31%。资金方面，该股资金流入57.8936万港元，流出73.1732万港元。泰德医药股票所在的药品行业中，整体跌幅为0.78%。其相关个股中，德琪医药-B、凯莱英、开拓药业-B涨幅较大，振幅较大的相关个股有君圣泰医药-B、德琪医药-B、凯莱英，振幅分别为10.31%、9.72%、9.28%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304110706a4493f60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304110706a4493f60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2616354378","title":"泰德醫藥盤中異動 臨近午盤快速跳水5.07%報24.320港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616354378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616354378?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 11:44","pubTimestamp":1772423065,"startTime":"0","endTime":"0","summary":"2026年03月02日临近午盘11时44分，泰德医药股票出现异动，股价急速下跌5.07%。截至发稿，该股报24.320港元/股，成交量4.9万股，换手率0.07%，振幅4.37%。资金方面，该股资金流入84.5758万港元，流出38.6608万港元。泰德医药股票所在的药品行业中，整体跌幅为1.26%。其相关个股中，泰凌医药、金嗓子、海王英特龙涨幅较大，振幅较大的相关个股有天大药业、君圣泰医药-B、宝济药业-B，振幅分别为13.60%、12.55%、12.20%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302114425954289f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302114425954289f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614818426","title":"半年內股價腰斬，泰德醫藥(03880)年度盈喜利好也難獲市場青睞？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614818426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614818426?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 15:52","pubTimestamp":1772265137,"startTime":"0","endTime":"0","summary":"2月26日盘前，泰德医药发布2025年年度盈喜。年度收入与利润齐升，泰德医药自然在当日赢得二级市场的积极反馈。盈喜发布次日，泰德医药股价开盘迅速下跌，早盘跌幅一度达到6.58%，几乎回吐了前日的全部涨幅。去年12月30日，泰德医药迎来基石解禁。从盘面来看，在基石解禁当日及次日，泰德医药股价分别小幅收涨0.94%和1.20%。不过2月5日，泰德医药股价收跌5.56%，盘中最低触及21.50港元上市新低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2614004575","title":"泰德醫藥盤中異動 早盤股價大跌5.16%報25.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614004575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614004575?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 10:13","pubTimestamp":1772158437,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘10时13分，泰德医药股票出现异动，股价急速下挫5.16%。截至发稿，该股报25.380港元/股，成交量3.13万股，换手率0.04%，振幅5.23%。资金方面，该股资金流入10.8334万港元，流出66.3282万港元。泰德医药股票所在的药品行业中，整体涨幅为0.28%。其相关个股中，九源基因、先声药业、康龙化成涨幅较大，振幅较大的相关个股有宝济药业-B、培力农本方、德琪医药-B，振幅分别为12.47%、10.45%、8.28%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227101357a7249dfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227101357a7249dfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614098320","title":"泰德醫藥盤中異動 早盤大幅上漲5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614098320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614098320?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 10:00","pubTimestamp":1772071228,"startTime":"0","endTime":"0","summary":"2026年02月26日早盘10时00分，泰德医药股票出现异动，股价急速上涨5.78%。截至发稿，该股报26.740港元/股，成交量3.77万股，换手率0.05%，振幅5.54%。泰德医药股票所在的药品行业中，整体涨幅为0.05%。其相关个股中，泰德医药、英硅智能、九源基因涨幅较大，振幅较大的相关个股有长风药业、泰德医药、英硅智能，振幅分别为6.68%、5.54%、4.74%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602261000289542060e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602261000289542060e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614306348","title":"泰德醫藥(03880)發盈喜，預期年度經調整淨利潤約2億元至2.3億元 按年增加約16.3%至33.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614306348","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614306348?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 08:15","pubTimestamp":1772064952,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药 发布公告，预期集团截至2025年12月31日止年度的收入约人民币5.55亿元至5.85亿元，较截至2024年12月31日止年度的收入约4.42亿元增加约25.5%至32.3%;集团截至2025年12月31日止年度的利润约2亿元至2.3亿元，较截至2024年12月31日止年度的利润约5920万元增加约237.8%至288.5%。此外，预期集团截至2025年12月31日止年度的经调整净利润约2亿元至2.3亿元，较截至2024年12月31日止年度的经调整净利润约1.72亿元增加约16.3%至33.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰德医药(03880)发盈喜，预期年度经调整净利润约2亿元至2.3亿元 同比增加约16.3%至33.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03880"],"gpt_icon":0},{"id":"1102819405","title":"泰德醫藥（浙江）股份有限公司2025年度營收約5.55億元至5.85億元，經調整淨利潤約2.00億元至2.30億元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102819405","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102819405?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 08:06","pubTimestamp":1772064391,"startTime":"0","endTime":"0","summary":"根据公告，泰德医药（浙江）股份有限公司2025年度营收预期从2024年的约人民币4.422亿元增长至约人民币5.55亿元至5.85亿元，同比增幅约25.5%至32.3%。公司同时预计2025年度经调整净利润将从2024年的约人民币1.72亿元增长至约人民币2.00亿元至2.30亿元，同比增幅约16.3%至33.7%。经调整净利润的提升在收入增长之外，也得益于公司通过优化运营管理体系获得的成本节约与效率提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2611906320","title":"泰德醫藥盤中異動 快速下挫5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611906320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611906320?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 13:46","pubTimestamp":1770875174,"startTime":"0","endTime":"0","summary":"2026年02月12日下午盘13时46分，泰德医药股票出现波动，股价大幅跳水5.55%。截至发稿，该股报24.500港元/股，成交量13.55万股，换手率0.18%，振幅6.17%。泰德医药股票所在的药品行业中，整体涨幅为0.00%。其相关个股中，中国医疗集团、英硅智能、宝济药业-B涨幅较大，振幅较大的相关个股有宝济药业-B、中国医疗集团、英硅智能，振幅分别为13.45%、10.07%、9.02%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121346149540d943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121346149540d943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2610661084","title":"泰德醫藥盤中異動 股價大漲5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610661084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610661084?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 14:42","pubTimestamp":1770705725,"startTime":"0","endTime":"0","summary":"2026年02月10日下午盘14时42分，泰德医药股票出现波动，股价快速上涨5.11%。截至发稿，该股报24.700港元/股，成交量9.74万股，换手率0.13%，振幅6.13%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。泰德医药股票所在的药品行业中，整体涨幅为1.48%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021014420597a597b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021014420597a597b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2609374872","title":"泰德醫藥(03880)：中國證監會就公司H股全流通申請發出備案通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374872","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374872?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 19:50","pubTimestamp":1770292210,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药(03880)发布公告，本公司于2026年2月5日收到中国证监会就转换并上市向本公司发出的备案通知书。根据备案通知书，有关转换并上市的中国证监会备案已告完成，若本公司自备案通知书出具之日起12个月内未完成股份转换，拟继续推进的，应当向中国证监会更新备案材料。于本公告日期，转换并上市的实施计划详情尚未最终确定。本公司将根据上市规则及适用法律法规的要求就转换并上市的进展情况作出进一步公布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2609967373","title":"港股破發股泰德醫藥跌5.57%創新低 上市募5.14億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967373","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609967373?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 18:09","pubTimestamp":1770286169,"startTime":"0","endTime":"0","summary":"中国经济网北京2月5日讯 泰德医药 港股今日收报23.42港元，跌幅5.565%，今日盘中最低价21.50港元，创上市以来最低价。目前该股处于破发状态。　　泰德医药的最终发售价为30.6港元，所得款项总额为514.08百万港元，扣除基于最终发售价的估计应付上市开支85.31百万港元，所得款项净额为428.77百万港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260205/32001359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03880","BK4585","VT","BK4588","BK1141","VXUS"],"gpt_icon":0},{"id":"1174185938","title":"泰德醫藥（03880）披露1月月報，股本結構維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174185938","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174185938?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 17:45","pubTimestamp":1770198309,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司于2026年2月4日发布截至2026年1月31日的月报。公告显示，公司已发行股本总数维持不变，H股和非上市股份数量无新增发行或回购活动，股本结构整体保持稳定。公司现有注册及已发行H股73,598,888股，无库存股；另有非上市股份68,201,112股，截至报告期末，两类股份合计141,800,000股。公司在公告中确认，已遵守香港联合交易所有限公司证券上市规则及相关法律法规规定，所有股份变动事项均经董事会授权并符合上市守则要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2609228311","title":"泰德醫藥盤中異動 下午盤股價大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609228311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609228311?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 13:11","pubTimestamp":1770181879,"startTime":"0","endTime":"0","summary":"2026年02月04日下午盘13时11分，泰德医药股票出现异动，股价急速下挫5.25%。截至发稿，该股报25.620港元/股，成交量6.03万股，换手率0.08%，振幅4.36%。资金方面，该股资金流入124.039万港元，流出24.5652万港元。泰德医药股票所在的药品行业中，整体跌幅为0.76%。其相关个股中，白花油、劲方医药-B、德琪医药-B涨幅较大，振幅较大的相关个股有德琪医药-B、英硅智能、白花油，振幅分别为8.23%、7.46%、7.23%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204131120a47a556c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204131120a47a556c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2609631121","title":"泰德醫藥創歷史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2609631121","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609631121?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 13:11","pubTimestamp":1770181875,"startTime":"0","endTime":"0","summary":"格隆汇2月4日丨泰德医药(03880.HK)跌4.96%，报25.7000港元，股价创历史新低，总市值36.44亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204131510a6d14df6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204131510a6d14df6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2607012929","title":"泰德醫藥01月30日主力淨流入31.1萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2607012929","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607012929?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 16:15","pubTimestamp":1769760952,"startTime":"0","endTime":"0","summary":"01月30日, 泰德医药股价涨0.44%，报收27.40元，成交金额1204.5万元，换手率0.57%，振幅1.91%，量比3.61。泰德医药今日主力资金净流入31.1万元，上一交易日主力净流出0万元。该股近5个交易日上涨1.03%，主力资金累计净流入165.2万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入74.1万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162312a6bf38e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162312a6bf38e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03880"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}